1.1 The evidence indicated insufficient patient benefit in terms of radiation dose reduction and increased throughput to justify its cost. No evidence was identified on patient benefits from the EOS ...
PARIS--(BUSINESS WIRE)--Regulatory News: EOS imaging (Paris:EOSI) (Euronext, FR0011191766 - EOSI - Eligible PEA - PME), a leader in 2D/3D orthopedic medical imaging and software solutions for 3D ...
PARIS--(BUSINESS WIRE)--Regulatory News: EOS imaging (Euronext, FR0011191766 - EOSI - Eligible PEA - PME) (Paris:EOSI), a leader in 2D/3D orthopedic medical imaging and software solutions for 3D ...
CARLSBAD, Calif., June 07, 2021 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq: ATEC), is a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery. Centered ...
Alphatec is pulling out of its agreement to acquire EOS Imaging because of negative impacts on the market caused by the novel coronavirus [COVID-19]. Carlsbad, CA-based Alphatec said based upon its ...
EOS imaging is a global medical device company that designs, develops and markets innovative, low dose 2D/3D full body and weight-bearing imaging, rapid 3D modeling of EOS patient X-ray images, ...
PARIS, May 12, 2021 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq: ATEC) and EOS IMAGING, S.A. are pleased to report strong progress in the tender offer filed by ATEC for the common shares and ...
Ongoing Impacts of COVID-19 Pandemic Constitute “Material Adverse Effect” Company Intends to Explore Other Strategic Collaborations with EOS Terminates Debt Commitment of up to $160 Million to Finance ...
EOS 2D/3D X-ray imaging system: diagnostics consultation document (PDF format) EOS 2D/3D X-ray imaging system: assessment report EOS 2D/3D X-ray imaging system: final protocol EOS 2D/3D X-ray imaging ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback